Fakih, Rami
Matiello, Marcelo
Chitnis, Tanuja
Stankiewicz, James M. http://orcid.org/0000-0003-4750-2756
Funding for this research was provided by:
Merck Serono
National Multiple Sclerosis Society
Article History
Received: 18 June 2018
Revised: 20 August 2018
Accepted: 4 September 2018
First Online: 10 September 2018
Compliance with ethical standards
:
: RF declares no conflict of interests. MM was a consultant for TerumoBCT and Octapharma. TC has received consulting/advisory fees from Biogen and Celgene, and serves on clinical trial advisory committees for Novartis and Sanofi-Genzyme. JS was a consultant for Biogen Idec, Genzyme, Celgene, Bayer, and EMD Serono.
: All subjects gave their informed consent prior to their inclusion in the study. The Partners Institutional Review Board approved this study.